description | Laurent Pharmaceuticals is a private orphan drug company developing a first-in-class oral therapy with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. Laurent has a clinical stage drug development program (LAU-7b) addressing the compromised immuno-inflammatory response in Cystic Fibrosis (CF), a critical but still enigmatic pathogenic pathway leading to pulmonary insufficiency in CF patients. |
keywords |
Laurent Pharmaceuticals,private company,COVID-19,rare diseases,cystic fibrosis,respiratory,small molecule,first-in-class,disease-modifying,inflammation,infection,Pseudomonas aeruginosa,clinical,Phase 1b |
introduction |
laurentpharma.com There are 1 links were found on the page. |
update time | 2020-10-11 14:28:30 |
type: text
text: BIOCOM 2019
link: biocomglobalpartnering.org
behavior: follow